Researchers noted that if it is given in the early stage of the disease it slowed down the rate of deterioration of the brain cells resulting in more time for the patients to remain lucid.
Advertisement
Against that gloomy backdrop come provocative results from two high-profile clinical trials, presented today at the Alzheimer’s Association worldwide Conference in Washington, D.C.
While doctors are now able to see the difference between a healthy brain and one affected by Alzheimer’s, the study emphasizes the importance of detecting Alzheimer’s-like changes early.
Schenning didn’t have amyloid measurements for these people; other studies have suggested that the people most at risk may have brewing cognitive problems already.
Stroke: Exercise improves blood flow and strengthens the heart muscles therefore people who exercise regularly are at lower risks of receiving a stroke.
While there’s plenty of evidence to show that regularly breaking a sweat may reduce the risk of Alzheimer’s disease and other forms of dementia, much of that research has previously been conducted on healthy individuals. Until then, the aging population is constantly being exposed to the dangers that dementia and Alzheimer’s in particular present.
The study was validated through the analysis of a new and independent sample of 27 participants.
Researchers pooled data from two earlier trials, Expedition and Expedition 2, and a later extension study involving the same participants. “It’s something we need to investigate more deeply”.
“Equally important is the possibility of using saliva to find targets for treatment to address the metabolic component of Alzheimer’s, which is still not well understood”, Sapkota notes. “You can’t ask for more than that”. It’s especially exciting for Sherzai since it could be used in clinic, or even community, settings.
Note: We’ll also be applying our systematic criteria to some of the media coverage emerging from the conference this week.
The progressive brain disorder is the sixth leading cause of death in America and affects almost 5 million Americans. This number is only expected to increase along with the cost of the disease.
“
All we can say at this point is there appears to be a faster trajectory for women than men”, {
1618515199} Dr. P. Murali Doraiswamy, a professor of psychiatry at the Duke Institue for Brain Sciences and senior author of the study. Together, she says, they may hold the key to actually slowing down and possibly even reversing progression of the disease.
Taking a longer term vision, another set of studies at AAIC 2015 reviewed early-stage results on three types of investigational drugs that suggest they have the potential to work across brain diseases that cause dementia, including Alzheimer’s, Parkinson’s and Lewy Body dementia, based on small preliminary studies in animal models and test tubes.
It has been demonstrated that poor sleep quality might lead to memory problems, and this raises the risk of getting Alzheimer’s disease.
Positive results would be a pivotal moment in the fight against the disease, as existing drugs only tackle the symptoms, making daily living tasks a little easier.
The results of their trials show that Solanezumab prevents this attachment, thus stopping the progress of the disease.
“When that blockbuster drug comes”, said Isaacson.
Advertisement
Furthermore, for all we know, the onset of the disease could be the moment when it can be cured.
